Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake-Reference-Cited by-同舟云学术

Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake

Published:2017-12-12 Issue:8 Volume:142 Page:1712-1722
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Kaji Kosuke¹^ORCID,Nishimura Norihisa¹,Seki Kenichiro¹,Sato Shinya¹,Saikawa Soichiro¹,Nakanishi Keisuke¹,Furukawa Masanori¹,Kawaratani Hideto¹,Kitade Mitsuteru¹,Moriya Kei¹,Namisaki Tadashi¹,Yoshiji Hitoshi¹

Affiliation:

1. Third Department of Internal Medicine; Nara Medical University; Kashihara Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference45 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2012

2. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

3. Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results;Kerbel;J Clin Oncol,2001

4. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

5. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial;Bruix;J Hepatol,2012

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperglycemia-driven signaling bridges between diabetes and cancer;Biochemical Pharmacology;2024-11

2. The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-10

3. Atrial fibrillation in cancer, anticancer therapies, and underlying mechanisms;Journal of Molecular and Cellular Cardiology;2024-09

4. Metabolic reprogramming in septic acute kidney injury: pathogenesis and therapeutic implications;Metabolism;2024-09

5. Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies;European Journal of Pharmacology;2024-09